Skip to main content

Table 1 The characteristics of study samples

From: Prevalence of CCR5delta32 in Northeastern Iran

 

Wild type

Mutantb

Heterozygote

Total

Sexa

46.1 (m), 53.9 (f)

100.0 (f)

45.5 (m), 54.5 (f)

45.9 (m), 54.1 (f)

Age (yr)

46.09 ± 7.25

37.00

46.45 ± 8.12

46.1 ± 7.27

Weight (Kg)

71.92 ± 13.27

61.2

77.11 ± 11.8

72.04 ± 13.2

Height (m)

1.62 ± .09

1.51

1.64 ± .10

1.62 ± .1

BMI

27.5 ± 4.79

26.84

29.21 ± 6.29

27.5 ± 4.8

Inflammatory marker

 Hs-CRP

1.64 (3.11–1.00)

0.75

1.45 (3.40–0.87)

1.62 (3.10–1.00)

Smoking

 Non-smokera

63.5

100.0

81.8

64.1

 Ex-smokera

10.0

0.0

18.2

9.7

 Current smokera

26.5

0.0

0.0

26.2

Diabetes

 Diabetic conditiona

15.4

0.0

20.0

15.5

Biochemical parameters

 Glucose (mg/dL)

82.0 (92.0–74.5)

71.00

82.0 (96.0–74.0)

82.0 (92.0–74.5)

 Cholesterol (mg/dL)

187.00 (214.00–163.00)

175.00

182.00 (233.00–153.00)

187.00 (214.00–163.00

 HDL (mg/dL)

41.5 ± 9.0

39.30

41.43 ± 10.82

41.5 ± 9.0

 Triglyceride (mg/dL)

116.0 (172.0–81.50)

74.00

92.00 (210.00–74.00)

115.0 (172.0–81.50)

 LDL (mg/dL)

118.88 (141.6–95.75)

102.06

121.88 (160.80–84.00)

118.92 (141.6–95.75)

  1. The results showed as mean ± SD and median (IQ3-IQ1) for normal and abnormal distribution data, respectively. a The numbers represent percentage of prevalence; b mutant group have only one subject